Systemic and Cardiac Microvascular Dysfunction in Hypertension
Alessandro Durante1, Alessandro Mazzapicchi2, Martina Baiardo Redaelli3
1Interventional and Clinical Cardiology Unit, Policlinico San Marco, 24040 Zingonia, Italy.
Hypertension damages the microcirculation, leading to organ damage. Early detection and interventions targeting blood pressure, endothelial function, and oxidative stress are crucial for mitigating complications.
Area of Science:
- Cardiovascular Science
- Nephrology
- Neurology
- Ophthalmology
Background:
- Hypertension significantly impacts the microcirculation, leading to structural and functional changes.
- The microcirculation is vital for oxygen and nutrient exchange, maintaining tissue homeostasis.
- Hypertensive microvascular alterations include remodeling and rarefaction, increasing vascular resistance and causing end-organ damage.
Purpose of the Study:
- To review the profound impact of hypertension on microcirculation.
- To elucidate the pathophysiological mechanisms of hypertensive microvascular dysfunction.
- To highlight the importance of early detection and therapeutic interventions.
Main Methods:
- Literature review focusing on microvascular changes in hypertension.
- Analysis of pathophysiological mechanisms including endothelial dysfunction, oxidative stress, and fibrosis.
- Synthesis of current understanding of hypertension's effects on organ systems.
Main Results:
- Hypertension causes microvascular remodeling and rarefaction, impairing vessel density and elasticity.
- Key mechanisms include impaired nitric oxide (NO) bioavailability, increased reactive oxygen species (ROS), inflammation, and fibrosis.
- These changes lead to progressive vascular stiffening and dysfunction, affecting the heart, kidneys, brain, and retina.
Conclusions:
- Microvascular dysfunction is pivotal in hypertension-related complications.
- Optimizing blood pressure control is essential.
- Therapeutic strategies targeting endothelial function, oxidative stress, and vascular remodeling are critical for mitigating systemic consequences and reducing disease burden.
More Related Videos
08:21Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
Published on: July 21, 2023
08:22Combined Intravital Microscopy and Contrast-enhanced Ultrasonography of the Mouse Hindlimb to Study Insulin-induced Vasodilation and Muscle Perfusion
Published on: March 20, 2017
Related Concept Videos
Pathophysiology of Heart Failure
Hypertension and Regulation of Blood Pressure
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Disorders of the Autonomic Nervous System
Raynaud's disease, also known as Raynaud's...
Heart Failure Drugs: Diuretics
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
